Capecitabine in Treating Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Skin

NCT01823679 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

2

Enrollment

OTHER

Sponsor class

Stopped Low accrual

Conditions

Squamous Cell Carcinoma of the Skin
Recurrent Skin Cancer

Interventions

DRUG: Capecitabine

Sponsor

Stanford University

Collaborators

[object Object]